Summary
Johnson & Johnson (JNJ) filed an 8-K on October 13, 2014, to report its financial results for the third quarter and the first nine months of 2014, ending September 28, 2014. The filing includes a press release detailing sales and earnings performance, as well as supplementary financial data. Investors should review these results to understand the company's recent operational and financial condition. The core of this report lies in the attached press release and supplementary financial statements. These documents provide the official figures for JNJ's performance during the specified periods, allowing for an assessment of revenue generation, profitability, and overall financial health. This information is crucial for investors looking to make informed decisions about their JNJ holdings.
Key Highlights
- 1JNJ filed an 8-K on October 13, 2014, to announce Q3 and year-to-date 2014 financial results.
- 2The report covers the period ending September 28, 2014.
- 3Key financial metrics such as sales and earnings for the quarter and nine months are provided.
- 4The filing includes an official press release from JNJ detailing these results.
- 5Unaudited comparative supplementary sales data and condensed consolidated statements of earnings are attached.
- 6This 8-K serves as the primary source for JNJ's Q3 2014 financial performance disclosure.